Latest Pharmacology Stories
LONDON, May 24, 2013 /PRNewswire/ -- The potential of the pulmonary route as a non-invasive administration for systemic delivery of therapeutic agents has been receiving undeniable attention with the recent advances of the inhalation drug delivery showing significant promise. The crucial formulation considerations for orally inhaled products together with those of a delivery device play a major role in the efficiency of pulmonary delivery, and great strides have been made in...
DURHAM, N.C., May 23, 2013 /PRNewswire/ -- Parata Systems, a leader in pharmacy automation, announced today it has been recognized by Today's Caregiver magazine as a 2013 "Caregiver Friendly(®) Award" recipient. The awards recognize products, services, books and media created with the needs of caregivers in mind. Parata was recognized in the "Products" category for its Parata PASS(TM) (patient adherence strip system) packaging. Parata PASS organizes medications into a strip of unit-...
SCHOFIELD, Wis., May 23, 2013 /PRNewswire/ -- PuraMed BioScience(®), Inc., (OTCBB: PMBS) a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced that Ludlow Research re-issued its research opinion on the company based on low market capitalization valuation. Report Highlights Non-Prescription, All Natural Product to Treat Migraine Headaches Clinical Trials Show the Product Outperforms #1 Prescription Competitor Currently...
BALTIMORE, May 23, 2013 /PRNewswire/ -- Ameritox, the nation's leader in pain medication monitoring, has been selected by Progressive Medical, Inc. to become part of its Urine Drug Monitoring (UDM) network to help clients manage pharmacy costs and improve the clinical outcomes for injured workers. Progressive Medical, a leading pharmacy benefit manager in the workers' compensation industry, has used UDM in its overall medication compliance and pain management strategy for several...
WESTFIELD, N.J., May 23, 2013 /PRNewswire-USNewswire/ -- Stephen L. DeFelice, M.D., Founder and Chairman of FIM, The Foundation for Innovation in Medicine, released a new video criticizing mainstream health care cost projections of Medicare, Medicaid and Obamacare, among others, because they omit the discovery of cures. He cites a boom in technology, including gene modification and new organ growth as inevitable in curing many of our major costly diseases. (To view the video and...
Public Advisory Panel Accepts FDA's Class II Re-Classification Suggestion FREDERICK, Md., May 23, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very effective, safe consumer medical devices, comments on the FDA panel meeting for non-thermal shortwave diathermy: The FDA's Public Advisory Panel Reclassification - Pulsed Shortwave Therapy Meeting was held on May 21, 2013 in Gaithersburg, MD, USA. The focus of the meeting was very narrow, in that the...
Clinical program supports accelerated approval filing with CFDA in China, and a Phase 3 program in the U.S. SAN DIEGO and SHANGHAI, May 23, 2013 /PRNewswire/ -- Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun's...
- Fastest growing Top 10 pharmaceutical business in the U.S., Europe & Japan in 2012 NEW BRUNSWICK, N.J., May 23, 2013 /PRNewswire/ -- At a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced they anticipate submitting more than 10 new product filings and more than 25 significant brand line extensions by 2017. To view the multimedia assets associated with this release, please click:...
SAN DIEGO, May 23, 2013 /PRNewswire/ -- MedVantx, Inc., the company that has pioneered a unique direct to consumer pharmaceutical distribution channel announced today the Company has completed a major expansion of its home delivery platform to manage $1.5B in pharmaceutical products and the upgrade of its systems to offer a level of quality akin to cGMP facilities in its specialty home delivery pharmacy in Sioux Falls, SD. The Company provides leading pharmaceutical manufacturers,...
-- Clinical Trial in Patients with Huntington's Disease Slated to Begin Next Quarter -- SEATTLE, May 23, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug Application (IND) to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an enzyme expressed in areas of the brain linked to a wide range of diseases that affect...
Latest Pharmacology Reference Libraries
The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...
Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...
Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.
